According to a press release from the Decatur Memorial Hospital in Decatur Ill., after their having completed a clinical trial evaluating C-11 Choline PET CT and in men who have suffered a biochemical relapse of prostate cancer, they are now offering the C-11 Choline PET CT commercially.
C-11 Choline uses an FDA approved tracer which, after injection, highlights more precisely than current tracers the location of prostate cancer tumors. This technology might allow men experiencing an early prostate cancer recurrence to “go after” these tumors before they spread even farther into the body.
In the largest published study in the U.S. on C-11 Choline imaging, there was a 32 percent increased detection rate of prostate cancer lesions which were not identified on conventional CT scan and bone scan.
At this time, with this approval Decatur Memorial Hospital is one of a very few hospitals in the U.S. able to provide this imaging procedure.
How to contact Decatur Memorial Hospital:
2300 N. Edward Street
Decatur, Illinois 62526